#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Pattern of invasion of oral squamous cell carcinoma and its relation to the presence of nodal metastases – a review


Authors: K. Kopecká 1,2;  R. Pink 1,2
Authors‘ workplace: Department of Oral and Maxillofacial Surgery, University Hospital Olomouc, Czech Republic 1;  Faculty of Medicine, Palacký University Olomouc, Czech Republic 2
Published in: ACTA CHIRURGIAE PLASTICAE, 65, 1, 2023, pp. 28-33
doi: https://doi.org/doi: 10.48095/ccachp202328

Introduction

Oral cavity tumors represent 2% of all malignancies and they are the cause of nearly 180,000 deaths per year worldwide [1]. However, their incidence manifests a significant geographical variability. In Papua New Guinea, and Central and South Asia, oral cavity tumors are actually the most common cause of death in general, which can be explained by the consumption of betel nut, which is highly popular among the local population. In these geographical latitudes, oral cavity carcinomas account for up to 1/3 of all cancers [2,3]. In European countries, these carcinomas are the most prevalent in France and Hungary and they even represent the second most common type of cancer in the male population [4].

Squamous cell carcinoma is the most common of all malignant tumors of the oral cavity [5]. Squamous cell carcinoma accounts for up to 95% of all head and neck cancers, and its 5-year survival rate ranges from 50 to 60% [6].

The prognosis and treatment type depends on many factors, the most important being the staging, i.e. the TNM classification, which can be determined preoperatively on the basis of a combination of clinical examination and imaging methods that can predict 60–70% of nodal metastases, which are frequent metastases for this type of tumor [7,8]. If the oral cavity and oropharyngeal squamous cell carcinomas metastasize, the cervical lymph nodes are affected most often [9]. The presence or absence of lymph node metastases is an important factor that determines the survival and prognosis of patients suffering from oral cavity and oropharyngeal squamous cell carcinomas [10–13]. The presence of nodal metastases reportedly reduces the overall survival by up to 50% [12,14,15].

In the case of early-stage squamous cell carcinomas of the oral cavity ­(T1-T2N0M0), the presence of nodal metastases is not expected; the distance of the tumor from the resection margins, which determines the necessity of postoperative adjuvant therapy (radiotherapy, chemotherapy or their combination) is the decisive factor. Ideally, the surgeon is trying to reach a free margins resection (R0) so that the distance between the tumor mass margin and the healthy tissue is > 5 mm in squamous cell carcinomas of the oral cavity (Fig. 1).

1. Resected tumor of the floor of the oral cavity. A surgeon is trying to reach free margins of resection (R0) so that the distance between the tumor mass margin and the healthy tissue is > 5 mm.
Resected tumor of the floor of the oral cavity. A surgeon is trying to
reach free margins of resection (R0) so that the distance between the tumor
mass margin and the healthy tissue is > 5 mm.

Extirpation of the tumor into macroscopically healthy tissue, often accompanied by an elective cervical dissection, is the main type of therapy for these carcinomas [10,11]. However, in the case of some tumors (T1-T2N0), standard treatment may not be successful depending on the pattern of the invasive tumor front [16,17].

One of the reasons for this treatment failure is the fact that a certain percentage of patients (5–40%) develop occult (sometimes also referred to as subclinical) nodal metastases already in the early stages of the oral cavity carcinoma ­(T1-2N0M0) [10,12,18,19]. These metastases are impossible to detect clinically or radiologically due to their very small size. The only way to detect them is to use light microscopy, i.e. detection is only possible postoperatively after a block neck dissection [12,18,20]. However, some occult metastases may also be "submicroscopic" in size, i.e. they remain unseen even to a light microscope during standard hematoxylin and eosin staining. Their largest dimension usually ranges from 0.2 to

2 mm, and submicroscopic metastases < 0.2 mm in the largest dimension are then referred to as isolated tumor cells (ITC) [21,22]. These can be detected immunohistochemically and/or using molecular analysis, but these methods are not routinely used in common practice [12,18–20,22]. Determination of the invasion pattern by a pathologist may be a definite and a rather important clue to the presence of nodal metastases in early stages of cancer [23,24]. On the basis of the available information, the pattern of invasion seems to be closely related to the very presence or absence of nodal metastases [8,16,17,23–25]. In contrast to submicroscopic occult metastases, the pattern of invasion can also be determined from excision biopsy specimen stained with hematoxylin and eosin [18].

The sources for this manuscript were mainly searched in Medline database, specifically from the articles published between 1989 and 2021. Key words for searching were oral squamous cell carcinoma and pattern of invasion. Articles that did not address the issue were excluded. Additional published sources were retrieved by searching the bibliography of major articles on the topic (Fig. 2).

2. A patient with oral squamous cell carcinoma of the floor of the mouth, cT2-3.
A patient with oral squamous cell carcinoma of the floor of the mouth,
cT2-3.

Discussion

An invasion pattern refers to the way in which the tumor tissue infiltrates the surrounding tissue [26]. When assessing the pattern of invasion, the histopathologist focuses on the "invasive front" of the tumor, which may have the following appearance:

1) "broad" tumor front – when viewed under microscope, the tumor is quite clearly separated from the host’s tissue, it pushes the tumor margin "broadly";

2) finger-like protrusions – the invasive tumor front invades the surrounding tissue in the form of finger-like protrusions;

3) tumor cell islets with >15 cells per islet;

4) tumor cell islets with <15 cells or individual tumor cells;

5) satellite tumor cells separated from the invasive tumor front by a distance of > 1 mm.

These five patterns of invasion can be classified into three groups: cohesive ­(invasion patterns 1–3), non-cohesive (invasion pattern 4), and widely dispersed (pattern 5), referred to as the "worst pattern of invasion" in English ­literature [26,27].

In the course of determination of the subsequent therapy in bulky oral cavity and oropharyngeal squamous cell carcinomas, tumor staging, which is nowadays essential despite the available histopathological, biochemical or immunochemical markers, is of the utmost importance [13,25]. On the other hand, in early stages of oral cavity and oropharyngeal tumors (T1-2N0M0), it is advisable to focus on other criteria (especially the histopathological ones) as well. These other criteria include the aforementioned invasion pattern – it is the criterion which is the best in predicting the metastatic potential of oral cavity squamous cell carcinomas [8,16,17,23–26, 29].

The advantage of this histopathological marker lies in its possible detection already from a biopsy specimen stained only with hematoxylin and eosin [25]. In these cases, classical staging is often insufficient to determine the prognosis of the disease, because in these early stages, some patients have already developed occult neck metastases that cannot be detected by any clinical or radiological examination [12,18,20]. Sometimes, it is even impossible to detect them in a standard biopsy specimen stained with hematoxylin and eosin; in such cases, these metastases are referred to as submicroscopic [18,19,22,30]. We can learn information about the metas­tatic potential (the ability and willingness of a tumor to metastasize, even submicroscopic ones) of a tumor just from the very area of the invasive tumor front. For this, the invasion pattern needs to be determined by a histopathologist. Based on the pattern, a clinician is then able to modify, and, if necessary, radicalize the therapy [17,24]. In effect, this means that squamous cell carcinomas with identical staging can and often do exhibit different clinical behaviors and growth patterns [24,28,29].

To determine the prognosis of oral cavity squamous cell carcinomas, a number of markers have been identified in the past, which were referred to as prognostic factors (depth of invasion, perineural invasion, distance of the tumor from the excision margins), but none of them has been completely reliable [28,29,31,32]. According to more recent findings, when assessing the pattern of tumor invasion and thus its aggressiveness, the histopathologist focuses on the “invasive front” of the tumor (from which the invasion pattern can be determined). On the basis of the available information, it seems that the most relevant information regarding the aggressiveness of the tumor and thus also the likely presence of nodal metastases, which is closely related to prognosis, can be acquired from the invasive front of the tumor [17,23,27,31,33–35] The invasive tumor front consists of 3–6 layers of cells or several islands or clusters of tumor cells at the tumor margin [36]. The most aggressive cells are located here, and the tumor is less differentiated than its other parts [32,36–40]. At the area of the invasive front, a histopathologist can detect other characteristics besides the pattern of invasion, including the degree of keratinization, the presence and extent of lymphocytic-plasmocytic infiltration, and nuclear polymorphism. Even though these characteristics can also be learned from the central parts of the tumor, they once again (similarly to the invasion pattern) have the greatest informative value in the area of the invasive front and they can also be connected to the prognosis of the cancer [27–29, 34,41].

Changes at the cellular level can be detected in the area of the invasive front of the tumor, which then lead to easier metastases of squamous cell carcinomas. The most important of these changes include loss of tumor cell adhesion (classified by invasion pattern – cohesive, non-cohesive or widely dispersed – see above), followed by a secretion of pro­teolytic enzymes, increased cell proliferation, and angiogenesis [38,39]. Multiple invasion patterns may be represented in the invasive front – the worst of these patterns is always considered in the classification [17].

In the invasive front of the tumor, we encounter increased secretion of the laminin glycoprotein, for example. On the surface of oral cavity squamous cell carcinoma cells, there are receptors for laminin, which trigger the secretion of enzymes upon binding of this protein. These enzymes then induce a rupture of the basement membrane by destruction of collagen IV and degradation of the aforementioned laminin. This process facilitates the invasion of tumor cells into the surrounding tissue [42]. Disruption of basement membrane integrity is essential for tumor invasion into the surrounding area and for metastatic spread (Fig. 3).

3. Oral squamous cell carcinoma of the floor of the mouth.
Oral squamous cell carcinoma of the floor of the mouth.

Secretion of the tenascin protein may also be increased at the invasive tumor front [24,43]. Increased tenascin production occurs physiologically during embryogenesis at the junction of epithelium and mesenchyme. At the time of embryogenesis, it is important for proper cell differentiation, motility, and cell proliferation [43]. If it is produced by tumor cells, the tumor is less differentiated, the tumor cells adhere to each other less (tenascin has "anti-adhesive effects"), thus a non-cohesive or widely dispersed invasion pattern in the invasive tumor front is more common when the expression of tenascin is increased [8,24,43,44].

Other changes at the molecular level in the invasive front include decreased synthesis of syndecan-1. It belongs to a group of proteoglycans found on the surface of cells. Syndecan-1 is mainly involved in cell adhesion. In a number of tumors (including oral cavity squamous cell carcinomas), we may encounter decreased expression of syndecan-1. Decreased expression of this glycoprotein correlates with the invasion pattern and thus with tumor prognosis. The lower the expression of syndecan-1, the lower the cell adhesion and the worse the invasion pattern. Therefore, tumors with lower syndecan-1 expression have a worse prognosis – they metastasize more frequently and more willingly [8,24,45].

Cortactin synthesis is another change at the molecular level that correlates with prognosis. Cortactin is a protein which plays a role in cell motility and invasion. Its increased expression means higher tumor aggressiveness, higher metastatic potential and therefore a worse prognosis [24,46]. Decreased expression of fibronectin is also common; fibronectin belongs among high-molecular-weight glycoproteins and it is involved in a number of processes at the cellular level – cell adhesion and migration. Its decreased expression in the cells of the invasive tumor front allows easier spreading of tumor cells, which once again results in a higher metastatic potential [24,47].

For this very reason, it is important to focus on the invasive front of the tumor; based on the front, we are able to determine the metastatic potential and adapt the therapy correspondingly [8,17,48].

Conclusion

The TNM classification is important in determination of the prognosis of oral cavity and oropharyngeal squamous cell carcinomas. However, the classification itself does not provide a lot of information about the prognosis of the tumor, as it has been shown recently. Therefore, it is advisable to take several markers into consideration – the invasion pattern belongs among the most important ones. The advantage of this marker lies in its easy detection by the histopathologist even from a sample commonly stained with hematoxylin and eosin. On the basis of this marker, we can predict the metastatic potential of squamous cell carcinomas of the oral cavity and oropharynx with relatively high probability. The metastatic potential may be high even in early stages (T1-T2N0M0). In these stages, occult (subclinical) metastases in the cervical lymph nodes may already be present.

When determining the invasion pattern, the histopathologist focuses on the areas in the “invasive front” of the tumor, in which the least differentiated tumor cells can be found. If more than one invasion patterns are present in the invasive tumor front, the worst of them is considered to be the decisive one. Therefore, it is advisable to include the deepest possible part of the tumor into the sample already at the time of diagnostic excision. From such a sample, a pathologist is already able to make a preoperative statement on the area of the invasive tumor front. Diagnostic excision from suspicious tumorous tissue should be bio­psied with first signs of a malignant lesion. Many changes at the molecular level occur in the area of the invasive front of squamous cell carcinomas of the oral cavity and oropharynx. However, these do not need to be identified and defined in order to determine prognosis because most of them will be reflected in the very invasion pattern. This means that unfavorable changes at the molecular level (such as the increased laminin production, decreased syndecan-1 expression, increased cortactin synthesis, etc.) will be reflected in an unfavorable invasion pattern and vice versa, i.e. by a lower tumor cell cohesion and easier spread of tumor cells. The unfavorable pattern of invasion (widely dispersed pattern, non-cohesive) is then manifested by a higher metastatic potential of oral cavity squamous cell carcinomas. In such a case, it is advisable to radicalize the therapy even in early stages ­(T1-T2N0M0) of squamous cell carcinomas of the oral cavity and oropharynx.

Whether it is necessary to increase the distance of the resection margins from healthy tissue in patients with unfavourable invasion type is still unclear. Currently, the minimum distance of tumour margins from healthy tissue is recommended to be 5mm in oral squamous cell carcinomas. Further research is needed in this area. However, based on the findings presented in this article, we anticipate that these patients will require more radicality in both surgical and subsequent oncologic treatment.

Roles of authors

Kateřina Kopecká – first author, performed majority of literature research, and wrote the whole manuscript;

Richard Pink – a co-author, designed the whole conception of this article, performed literature research and critically reviewed the article.

Disclosure: The authors have no conflicts of interest to disclose. The authors declare that this study has received no financial support. All procedures performed in this study involving human participants were in accordance with ethical standards of the institutional research committee and with the Helsinki declaration and its later amendments or comparable ethical standards.

Assoc. Prof. Richard Pink, MD, PhD

Department of Oral and Maxillofacial Surgery

University Hospital Olomouc

Zdravotníků 248/7

77900 Olomouc

Czech Republic

e-mail: richard.pink@fnol.cz

Submitted: 25. 7. 2022

Accepted: 19. 3. 2023

Kopecká K, Pink R. Pattern of invasion of oral squamous cell carcinoma and its relation to the presence of nodal metastases – a review. Acta Chir Plast 2023;
65(1): 28–33.


Sources

1. Bray F., Ferlay J., Soerjomataram I., et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018, 68(6): 394–424.

2. Pazdera J. Základy ústní a čelistní chirurgie. Olomouc: Univerzita Palackého v Olomouci. 2007.

3. Kamal AM. Pattern of lymph node metastasis in oral cancer. OJOR. 2020, 3(5).

4. Bryne M., Jenssen N., Boysen M. Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virchows Arch. 1995, 427(3): 277–281.

5. Stambuk HE., Karimi S., Lee N., et al. Oral cavity and oropharynx tumors. Radiol Clin North Am. 2007, 45(1): 1–20.

6. Jeelani T., Amin J., Rasheed R., et al. Invasive tumor front in oral squamous cell carcinoma: an independent prognostic factor. Int J Sci Rep. 2019, 5(6): 139–144.

7. Almangush A., Bello IO., Keski-Säntti H., et al. Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck. 2014, 36(6): 811–818.

8. Sharma M., Sah P., Sharma SS., et al. Molecular changes in invasive front of oral cancer. J Oral Maxillofac Pathol. 2013, 17(2): 240–247.

9. Lee AK. Basement membrane and endothelial antigens: their role in evaluation of tumor invasion and metastasis. Advances in immunohistochemistry. New York (USA): Raven Press. 1988, 363–393.

10. Fakih AR., Rao RS., Borges AM., et al. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg. 1989, 158(4): 309–313.

11. Ferlito A., Rinaldo A., Robbins KT., et al. Changing concepts in the surgical management of the cervical node metastasis. Oral Oncol. 2003, 39(5): 429–435.

12. Greenberg JS., El Naggar AK., Mo V., et al. Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making. Cancer. 2003, 98(3): 508–515.

13. Andersen PE., Shah JP., Cambronero E., et al. The role of comprehensive neck dissection with preservation of the spinal accessory nerve in the clinically positive neck. Am J Surg. 1994, 168(5): 499–502.

14. Johnson JT., Barnes EL., Myers EN., et al. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol. 1981, 107(12): 725–729.

15. Devaney SL., Ferlito A., Rinaldo A., et al. Pathologic detection of occult metastases in regional lymph nodes in patients with head and neck cancer. Acta Otolaryngol. 2000, 120(3): 344–349.

16. Parekh D., Kukreja P., Mallick I., et al. Worst pattern of invasion – type 4 (WPOI-4) and Lymphocyte host response should be mandatory reporting criteria for oral cavity squamous cell carcinoma: a re-look at the American Joint Committee of Cancer (AJCC) minimum dataset. Indian J Pathol Microbiol. 2020, 63(4): 527–533.

17. Bryne M., Nielsen K., Koppang HS., et al. Reproducibility of two malignancy grading systems with reportedly prognostic value for oral cancer patients. J Oral Patholog Med. 1991, 20(8): 369–372.

18. Rinaldo A., Devaney KO., Ferlito A. Immunohistochemical studies in the identification of lymph node micrometastases in patients with squamous cell carcinoma of the head and neck. ORL J Otorhinolaryngol Relat Spec. 2004, 66(1): 38–41.

19. Piffkò J., Bànkfalvi A., Ofner D., et al. Prognostic value of histobiological factors (malignancy grading and AgNOR content) assessed at the invasive tumour front of oral squamous cell carcinomas. Br J Cancer. 1997, 75(10):

1543–1546.

20. Ferlito A., Rinaldo A. False negative conventional histology of lymph nodes in patients with head and neck cancer. ORL J Otorhinolaryngol Relat Spec. 2000, 62(2): 112–114.

21. Dhawan I., Sandhu SV., Bhandari R., et al. Detection of cervical lymph node micrometastasis and isolated tumor cells in oral squamous cell carcinoma using immunohistochemistry and serial sectioning. J Oral Maxillofac Pathol. 2016, 20(3): 436–444.

22. Ferlito A., Shaha AR., Rinaldo A. The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx. Oral Oncol. 2002, 38(1): 3–5.

23. Lin NC., Hsu JT., Tsai KY. Survival and clinicopathological characteristics of different histological grades of oral cavity squamous cell carcinoma: a single-center retrospective study. PloS One. 2020, 15(8): e0238103.

24. Piffko J., Bánkfalvi A., Ofner D., et al. Standardized demonstration of silver-stained nucleolar organizer regions–associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa. Mod Pathol. 1997, 10(2): 98–104.

25. Ganly I., Patel S., Shah J. Early stage squamous cell cancer of the oral tongue – clinicopathologic features affecting outcome. Cancer. 2012, 118(1): 101–111.

26. Chatterjee D., Bansal V., Malik V., et al. Tumor budding and worse pattern of invasion can predict nodal metastasis in oral cancers and associated with poor survival in early-stage tumors. Ear Nose Throat J. 2019, 98(7): E112–E119.

27. Almangush A., Bello IO., Keski-Säntti H., et al. Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck. 2014, 36(6): 811–818.

28. Bryne M., Boysen M., Alfsen CG., et al. The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Res. 1998, 18(6B): 4757–4764.

29. Lydiatt WM., Patel SG., O’Sullivan B., et al. Head and neck cancers – major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017, 67(2): 122–137.

30. Sharma AK., Mishra P., Gupta S. Immunohistochemistry, a valuable tool in detection of cervical lymph node micrometastases in head and neck squamous cell carcinoma: a prospective study. Indian J Otolaryngol Head Neck Surg. 2013, 65(Suppl 1): 89–94.

31. Arduino PG., Carrozzo M., Chiecchio A., et al. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J Oral Maxillofac Surg. 2008, 66(8): 1570–1579.

32. Bryne M., Koppang HS., Lilleng R., et al. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992, 166(4): 375–381.

33. Yuen AP., Wei WI., Lam LK., et al. Results of surgical salvage of loco-regional recurrence of carcinoma of the tongue after radiotherapy failure. Ann Otol Rhinol Laryngol. 1997, 106(9): 779–782.

34. Brandwein‑Gensler M., Teixeira MS., Lewis CM., et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease‑free and overall survival. Am J Surg Pathol. 2005, 29(2): 167–178.

35. Tralongo V., Rodolico V., Luciani A., et al. Prognostic factors in oral squamous cell carcinoma. A review of the literature. Anticancer Res. 1999, 19(4C): 3503–3510.

36. Welkoborsky HJ., Gluckman JL., Jacob R., et al. Tumor biologic prognostic parameters in T1N0M0 squamous cell carcinoma of the oral cavity. Laryngorhinootologie. 1999, 78(3): 131–138.

37. Bryne M. Is the invasive front of an oral carcinoma the most important area for prognostication. Oral Dis. 1998, 4(2): 70–77.

38. Bankfalvi A., Piffko J. Prognostic and predictive factors in oral cancer: the role of invasive tumor front. J Oral Pathol Med. 2000, 29(7): 291–298.

39. Wilson DF., Jiang DJ., Pierce AM., et al. Oral cancer: role of the basement membrane in invasion. Aust Dent J. 1999, 44(2): 93–97.

40. Varsha BK., Radhika MB., Makarla S., et al. Perineural invasion in oral squamous cell carcinoma: case series and review of literature. J Oral Maxillofac Pathol. 2015, 19(3):

335–341.

41. Huang SH., Hwang D., Lockwood G., et al. Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity. Cancer. 2009, 115(7): 1489–1497.

42. Dissanayake U. Malignancy grading of invasive fronts of oral squamous cell carcinomas: correlation with overall survival. Transl Res Oral Oncol. 2017, 2(2): 2057178X1770887.

43. Huang W., Chiquet-Ehrismann R., Moyano JV., et al. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res. 2001, 61(23): 8586–8594.

44. Kurokawa H., Zhang M., Matsumoto S., et al. Reduced syndecan-1 expression is correlated with the histological grade of malignancy at the deep invasive front in oral squamous cell carcinoma. J Oral Pathol Med. 2006, 35(5): 301–306.

45. Yamada S., Yanamoto S., Kawasaki G., et al. Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma. Pathol Oncol Res. 2010, 16(4): 523–531.

46. Kosmehl H., Berndt A., Strassburger S., et al. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br J Cancer. 1999, 81(6): 1071–1079.

47. Bryne M., Koppang HS., Lilleng R. New malignancy grading is a better prognostic indicator than Borders’ grading in oral squamous cell carcinomas. J Oral Pathol Med. 1989, 18(8): 432–437.

48. Jones PL., Jones FS. Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol. 2000, 19(7): 581–596.

Labels
Plastic surgery Orthopaedics Burns medicine Traumatology
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#